J. Pascal

发表

Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990.

R. Groszmann, A. Burroughs, T. Sauerbruch, 1992, Journal of hepatology.

Weakness of mucosal barrier in portal hypertensive gastropathy of alcoholic cirrhosis. Effects of propranolol and enprostil.

J. Frexinos, P. Calès, J. Payen, 1995, Journal of hepatology.

Hemodynamic and pharmacokinetic study of tertatolol in patients with alcoholic cirrhosis and portal hypertension.

S. Urien, J. Vinel, P. Calès, 1993, Journal of hepatology.

Propranolol does not alter cerebral blood flow and functions in cirrhotic patients without previous hepatic encephalopathy

J. Vinel, P. Calès, G. Géraud, 1989, Hepatology.

Pharmacodynamic and pharmacokinetic study of propranolol in patients with cirrhosis and portal hypertension.

A. Ravaud, J. Vinel, P. Calès, 1989, British journal of clinical pharmacology.

Hemodynamic evaluation of molsidomine: A vasodilator with antianginal properties in patients with alcoholic cirrhosis

J. Vinel, P. Calès, J. Combis, 1990, Hepatology.

Mutations in the MHC class I-like candidate gene for hemochromatosis in French patients

J. Vinel, M. Roth, H. Coppin, 1997, Immunogenetics.

Verapamil has no effect on porto-hepatic pressure gradient, hepatic blood flow and elimination function of the liver in patients with liver cirrhosis.

J. Vinel, P. Calès, J. Combis, 1989, Journal of hepatology.

Atrial natriuretic peptide, plasma renin activity, plasma volume, systemic vascular resistance and cardiac output in patients with cirrhosis

P. Braquet, J. Vinel, P. Calès, 1989, Journal of gastroenterology and hepatology.

Pharmacokinetics of alphaIFN-2b in chronic hepatitis C virus patients undergoing chronic hemodialysis or with normal renal function: clinical implications.

L. Rostaing, J. Izopet, C. Thalamas, 1998, Journal of the American Society of Nephrology : JASN.

Colonic arterial spider in cirrhosis.

P. Calès, J. Payen, J. Pascal, 1991, Gastrointestinal endoscopy.

Relationships between blood flow and secretion in the isolated perfused canine pancreas

N. Vaysse, J. Boucard, J. Pascal, 1972, The Journal of physiology.

Histopathologic analysis of transjugular intrahepatic portosystemic shunts

H. Rousseau, J. Vinel, F. Joffre, 1997, Hepatology.

Haemodynamic effects of molsidomine and propranolol in patients with cirrhosis.

J. Vinel, J. Combis, J. Payen, 1996, British journal of clinical pharmacology.

Effect of propranolol on metabolic activity of the liver in patients with alcoholic cirrhosis.

J. Vinel, P. Calès, J. Voigt, 1988, Journal of hepatology.

Assessment of short‐term prognosis after variceal bleeding in patients with alcoholic cirrhosis by early measurement of portohepatic gradient

J. Vinel, J. Cassigneul, Voigt Jj, 1986, Hepatology.

The treatment of refractory ascites by the LeVeen shunt. A multi-centre controlled trial (57 patients).

M. Bourel, J. Capron, H. Michel, 1986, Journal of hepatology.

Gastroesophageal endoscopic features in cirrhosis: comparison of intracenter and intercenter observer variability.

P. Calès, J. Pascal, 1990, Gastroenterology.

Lack of effect of propranolol in the prevention of large oesophageal varices in patients with cirrhosis: a randomized trial. French-Speaking Club for the Study of Portal Hypertension.

D. Valla, D. Guyader, P. Blanc, 1999, European journal of gastroenterology & hepatology.

Effects of catecholamines and their inhibitors on the isolated canine pancreas. II. Dopamine.

N. Vaysse, J. Pascal, A. Ribet, 1977, Gastroenterology.

Effects of catecholamines and their inhibitors on the isolated canine pancreas. I. Noradrenaline and isoprenaline.

N. Vaysse, G. Fourtanier, J. Pascal, 1977, Gastroenterology.

Respiratory exchanges and acid-base balance during perfusion ofex vivo isolated pancreas

N. Vaysse, P. Roux, A. Lacroix, 1976, The American Journal of Digestive Diseases.

Exploration of pancreatic exocrine function by continuous infusion of secretin

J. Pascal, A. Ribet, N. Sannou, 1968, The American Journal of Digestive Diseases.

Genetic Heterogeneity of Hypervariable Region 1 of the Hepatitis C Virus (HCV) Genome and Sensitivity of HCV to Alpha Interferon Therapy

C. Pasquier, J. Puel, J. Izopet, 2000, Journal of Virology.

Baseline level and early suppression of serum HCV RNA for predicting sustained complete response to alpha‐interferon therapy

J. Puel, J. Izopet, J. Vinel, 1998, Journal of medical virology.

[Enterovenous fistula. An unusual complication of Crohn disease].

J. Vinel, B. Pradère, L. Alric, 1994, Gastroenterologie clinique et biologique.

Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection.

J. Puel, J. Izopet, J. Vinel, 1997, Gastroenterology.

Diffuse vascular ectasia of the antrum, duodenum, and jejunum in a patient with nodular regenerative hyperplasia. Lack of response to portosystemic shunt or gastrectomy.

J. Vinel, P. Calès, B. Pradère, 1993, Gut.

[Treatment of acute pancreatitis by glucagon: results of a controlled study].

G. Fourtanier, J. Pascal, R. Tournut, 1978, Gastroenterologie clinique et biologique.

Variability of the sum of bicarbonate and chloride concentrations in the pancreatic juice of the dog.

N. Vaysse, A. Kibet, J. Pascal, 1969, Scandinavian journal of gastroenterology.

Role of cholinergic mechanisms in the response to secretin of isolated canine pancreas.

N. Vaysse, P. Roux, A. Lacroix, 1975, Gastroenterology.

Response of the canine pancreas to duodenal acidification and secretin.

N. Vaysse, J. Pascal, D. Augier, 1968, Scandinavian journal of gastroenterology.

Better efficacy of a 12‐month interferon alfa‐2b retreatment in patients with chronic hepatitis C relapsing after a 6‐month treatment: A multicenter, controlled, randomized trial

J. Puel, J. Izopet, J. Seigneurin, 1998, Hepatology.

[Zieve's syndrome associated with calcifying pancreatitis. The role of the pancreas and lysolecithins in anemia].

J. Frexinos, J. Pascal, A. Ribet, 1967, La Presse medicale.

Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group.

T. Poynard, P. Calès, D. Lebrec, 1991, The New England journal of medicine.

Gastroesophageal endoscopic features in cirrhosis. Observer variability, interassociations, and relationship to hepatic dysfunction.

J. Fermanian, J. Vinel, P. Calès, 1990, Gastroenterology.

Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varices

H. Rousseau, J. Vinel, F. Joffre, 1999, Hepatology.

Incidence of large oesophageal varices in patients with cirrhosis: application to prophylaxis of first bleeding.

A. Ravaud, P. Gerin, J. Vinel, 1990, Gut.

Somatostatin in peptic ulcer bleeding--results of a double-blind controlled trial.

J. Faivre, J. Galmiche, R. Colin, 1983, International journal of clinical pharmacology research.

Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices.

P. Calès, J. Pascal, 1987, The New England journal of medicine.

Propranolol in the Primary Prevention of Upper Gastrointestinal Tract Haemorrhage in Patients with Cirrhosis of the Liver and Oesophageal Varices

P. Calès, J. Pascal, 2012, Drugs.

Could splenectomy worsen autoimmune manifestations?

J. Vinel, P. Calès, J. Pascal, 1990, Journal of internal medicine.

Transjugular intrahepatic portosystemic shunts using the Wallstent prosthesis: A follow-up study

H. Rousseau, J. Prieto, J. Vinel, 2004, CardioVascular and Interventional Radiology.

Transjugular intrahepatic portosystemic shunts in the treatment of refractory ascites: results in 48 consecutive patients.

H. Rousseau, J. Vinel, F. Joffre, 2000, Journal of vascular and interventional radiology : JVIR.

[Comparison of 3 methods of recording esophageal pH in the diagnosis of gastroesophageal acid reflux].

J. Cassigneul, Y. Ottignon, J. Voigt, 1984, Gastroenterologie clinique et biologique.

Prostate‐specific antigen in acute hepatitis and hepatocellular carcinoma

J. Izopet, B. Malavaud, P. Rischmann, 1999, The Prostate.

Involvement of calcium in macrophage leukotriene release during experimental cirrhosis

E. Pinelli, L. Alric, B. Pipy, 1996, Hepatology.

[How can we improve the prognosis for upper digestive hemorrhage? (excluding portal hypertension)].

J. Pascal, R. Tournut, 1977, Gastroentérologie Clinique et Biologique.

[Gastric rupture during colonoscopy following oxygen therapy by nasal intubation].

J. Vinel, M. Cherubin, J. Combis, 1995, Gastroentérologie Clinique et Biologique.

Relationship between bicarbonate, chloride, and volume flow at high secretory rates in the pancreatic juice of the dog.

N. Vaysse, J. Boucard, J. Pascal, 1968, Scandinavian journal of gastroenterology.

[Cholestatic hepatitis caused by carbimazole].

J. Vinel, P. Calès, J. Voigt, 1987, Presse medicale.

Intrahepatic portocaval shunt in patients waiting for transplantation.

H. Rousseau, L. Rostaing, J. Vinel, 1995, Transplantation proceedings.

Systemic and splanchnic hemodynamic effects of molsidomine in rats with carbon tetrachloride–induced cirrhosis

J. Vinel, P. Calès, B. Pipy, 1991, Hepatology.

The effects of linsidomine on portal hypertension

J. Vinel, W. Lautt, H. Desmorat, 1992, Hepatology.

[Disclosure of autoimmune hepatitis by interferon].

J. Payen, J. Voigt, J. Pascal, 1993, Gastroenterologie clinique et biologique.

Genetic heterogeneity of the envelope 2 gene and eradication of hepatitis C virus after a second course of interferon‐α

C. Pasquier, J. Puel, J. Izopet, 2002, Journal of medical virology.

[Hepatitis C virus reinfection after an intravenous drug injection].

J. Puel, J. Izopet, J. Payen, 1998, Gastroenterologie clinique et biologique.

[Natural history of esophageal varices in cirrhosis (from origin to rupture)].

P. Calès, J. Pascal, Pascal Jp, 1988, Gastroenterologie clinique et biologique.

Propranolol reduces the rebleeding rate during endoscopic sclerotherapy before variceal obliteration.

J. Vinel, P. Calès, B. Pradère, 1992, Gastroenterology.

Systemic and splanchnic hemodynamic effects of molsidomine in rats with carbon tetrachloride–induced cirrhosis

J. Vinel, P. Calès, B. Pipy, 1991, Hepatology.

Severe portal hypertensive gastropathy and antral vascular ectasia are distinct entities in patients with cirrhosis.

J. Vinel, J. Chayvialle, P. Calès, 1995, Gastroenterology.

[Treatment of bleeding oesophageal varices in cirrhotic patients with pitressin. A controlled study (author's transl)].

G. Fourtanier, J. Pascal, R. Tournut, 1978, Acta gastro-enterologica Belgica.

Transjugular intrahepatic portosystemic shunts using the Wallstent prosthesis: A follow-up study

H. Rousseau, J. Vinel, J. Bilbao, 2004, CardioVascular and Interventional Radiology.

Clinical and prognostic significance of portohepatic gradient in patients with cirrhosis.

J. Vinel, J. Cassigneul, J. Pascal, 1982, Surgery, gynecology & obstetrics.

[Treatment of hemorrhages by rupture of cardio-tuberous varices with transjugular intrahepatic portasystemic shunt].

H. Rousseau, J. Vinel, F. Joffre, 1993, Gastroenterologie clinique et biologique.

DIAGNOSIS AND MANAGEMENT OF HAEMOCHROMATOSIS SINCE THE DISCOVERY OF THE HFE GENE: A EUROPEAN EXPERIENCE

Robson, P. Gasparini, C. Patch, 2000, British journal of haematology.